Form 4 Filing for Inmune Bio, Inc.

Juda Scott, a director at Inmune Bio, Inc., exercised 14,801 common stock purchase warrants on July 2, 2026. These warrants were part of the April 2024 offerings and were amended on December 22, 2025. The exercise, representing 50% of the warrants held by Scott, resulted in the acquisition of 14,801 shares of common stock at a reduced price of $1.40 per share. This action was taken as part of an inducement agreement with the issuer, which extended the maturity date of the remaining 50% of the warrants from June 30, 2026, to December 31, 2027. Following the transaction, Scott holds 86,404 shares of common stock. The original exercise price for the warrants was $0.125 per share.